Amanda:
    Polly:
经典案例
当前位置:首页  >  经典案例  >  经典案例  >  案例分享-美国发明专利答辩博弈

案例分享-美国发明专利答辩博弈

活动时间:2021-10-14  点击量:29

美国发明专利答辩及电话会议案例分享

一个和审查员博弈了7, 一路爱恨情仇,无论怎么答复,他都能变着法子结合对比文件或者找到新的对比文件,如果克服了,那就再检索几个送你,看谁先受不了,可惜审查员这次磕上错的美国代理律师和申请人了,他怎么都没想到这些人越挫越勇了,***后还把案子折腾到审查员主管及美国专利Quality Review部门去了(审核--审查员的审查程序,及审查案子上是否公平公正)才争取到授权,实属不易, 值得分享。

Case Information】案子信息

申请号15/913,895 GBIS002

申请日:  2018-03-06

 

.Non-Final Office 2019-11-26

 102 rejection — Claims 1, 6-8, 13-15, and 17-20 were rejected d on prior art: U.S. Patent No.9775444.

 103 rejection — Claim 2, 3-5, 9-12, 16 were rejected d on prior arts: U.S. Patent No. 9775444, U.S. Publication No. 20170156508, U.S. Publication No. 20090144900, NPL 1, and NPL 2.

非***终审查意见 2019-11-26

 102问题 — 1, 6-8, 13-15, 17-20基于对比文件 U.S. Patent No.9775444无新颖性.

 103问题5个对比文件)  2, 3-5, 9-12, 16基于对比文件U.S. Patent No. 9775444, U.S. Publication No. 20170156508, U.S. Publication No. 20090144900, NPL 1, NPL 2无创造性.

 

Response to Non-Final Office 2020-02-25

 102/103 rejection — We amended the claims and argued.

答复非***终审查意见 2020-02-25

 102/103问题 — 我们修改了权利要求并相应争辩.

 

.Final Office 2020-03-09

 103 rejection  — Claims stand rejected d on same prior arts. 

***终审查意见 2020-03-09

 103问题 (维持一样的5个对比文件)权利要求基于与前次OA相同的对比文件被驳斥无创造性.

 

Response to Final Office 2020-04-09

 103 rejection — We continued to amend the claims and argue.

答复***终审查意见 2020-04-09

 103问题 — 我们继续修改权利要求并相应争辩.

 

Interview with Examiner 2020-04-13

The Examiner insisted that no claims were allowed and further search was required. Further, the Examiner asserted the specification did not appear to contain subject matter that could be used to get the case into allowance.

与审查员电话会议 2020-04-13

审查员坚称没有可授权的权利要求并且需要进一步检索. 而且, 审查员声称说明书也没有公开任何有助于授权的特征.

 

.Advisory Action 2020-04-20

The Examiner did not accept Applicants amendments and arguments, and asserted further search was required, along with an additional reference provided.

建议性审查意见 2020-04-20

审查员不接受任何修改和争辩意见,引用了1篇新的对比文件,并声称需要进一步检索.

 

Response to Advisory Action (with RCE) 2020-06-02

 103 rejection — We continued to amend the claims and argue.

答复建议性审查意见并请求继续审查(RCE 2020-06-02

 103问题 — 我们继续修改权利要求并相应争辩.

 

.Non-Final Office After 1st RCE 2020-06-15

 103 rejection — Claims stand rejected d on remained prior arts: U.S. Patent No. 9775444, U.S. Publication No. 20170156508, U.S. Publication No. 20090144900, NPL 1, and NPL 2; and newly added prior arts: U.S. Publication No. 20150071978, U.S. Publication No. 20090144900, U.S. Publication No. 20150296994.

【第1RCE后的非***终审查意见 2020-06-15

 103问题 (对比文件原5+ 3) 权利要求基于原有对比文件: U.S. Patent No. 9775444, U.S. Publication No. 20170156508, U.S. Publication No. 20090144900, NPL 1, and NPL 2;和新增对比文件: U.S. Publication No. 20150071978, U.S. Publication No. 20090144900, U.S. Publication No. 20150296994无创造性.

 

Response to Non-Final Office After 1st RCE 2020-09-14

 103 rejection — We continued to amend the claims and argue.

答复第1RCE后的非***终审查意见 2020-09-14

 103问题 — 我们继续修改权利要求并相应争辩.

 

.Final Office Action After 1st RCE 2020-09-22

 103 rejection — Claims stand rejected d on same prior arts as previous OA.

1RCE后的***终审查意见2020-09-22

 103问题 8个对比文件)— 权利要求基于与前次OA相同的对比文件被驳斥无创造性.

 

Response to Final Office After 1st RCE 2020-11-23

 103 rejection — We continued to amend the claims and argue.

【第1RCE后的***终审查意见2020-11-23

 103问题 — 我们继续修改权利要求并相应争辩.

 

.Advisory Action 2020-12-01

The Examiner did not accept Applicants amendments and arguments, and asserted further search was required.

建议性审查意见 2020-12-01

审查员没有接受任何修改和争辩意见,并声称需要进一步检索.

 

Response to Advisory Action (with RCE) 2020-12-22

The amendments and arguments were substantially the same as those file on November 23, 2020.

答复建议性审查意见并请求继续审查(RCE 2020-12-22

修改和争辩与2020-11-23提交的答复基本相同.

 

.Non-Final Office Action After 2nd RCE 2021-03-22

 112a rejection — Claims 10-11 were rejected under 35 U.S.C. 112 (a) as failing to comply with the written deion requirement.

 112b rejection — Claims 33-36 were rejected under 35 U.S.C. 112 (b) as being indefinite.

 103 rejection — Claims stand rejected d on remained prior art: U.S. Patent No. 9775444, U.S. Publication No. 20170156508, U.S. Publication No. 20090144900, NPL 1, NPL 2, U.S. Publication No. 20150071978, U.S. Publication No. 20090144900, and U.S. Publication No. 20150296994; and further added prior arts: China Patent No. 2805531, and U.S. Publication No. 20070251017.

2RCE后的非***终审查意见 2021-03-22

 112a问题 — 权10-11不符合公开充分的要求.

 112b问题 — 权33-36存在清楚性问题.

 103问题( 对比文件原8 + 2)— 权利要求基于原有对比文件: U.S. Patent No. 9775444, U.S. Publication No. 20170156508, U.S. Publication No. 20090144900, NPL 1, NPL 2, U.S. Publication No. 20150071978, U.S. Publication No. 20090144900, U.S. Publication No. 20150296994; 和新增对比文件: China Patent No. 2805531, U.S. Publication No. 20070251017无创造性.

 

Response to Non-Final Office After 2nd RCE 2021-07-14

 112a/b rejection — Amendments were made to overcome the 112a/b rejection.

 103 rejection — We continued to amend the claims and argue.

答复第2RCE后的非***终审查意见 2021-07-14

 112a/b问题 — 相应修改权利要求后克服112a/b问题


上一篇:暂无

上一篇:美国商标被提撤销应对案例